PharmiWeb.com - Global Pharma News & Resources
03-May-2019

Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019

CRANBURY, N.J., May 3, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2019 operating results on Thursday, May 9, 2019 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 9, 2019 at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast



Q3 Fiscal Year 2019 Financial Results Press Release                     

5/9/2019 at 7:30 a.m. ET



Q3 Fiscal Year 2019 Conference Call-Live                                     

5/9/2019 at 11:00 a.m. ET

US/Canada Dial-In Number:                                                           

1-800-667-5617

International Dial-In Number:                                                        

1-334-323-0509



Conference ID:                                                                                

7024541

Q3 Fiscal Year 2019 Conference Call-Replay                                 

5/9/2019-5/16/2019

US/Canada Dial-In Number:                                                           

1-888-203-1112

International Dial-In Number:                                                        

1-719-457-0820

Replay Passcode:                                                                            

7024541



Audio Webcast Live and Replay Access                                    

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/palatin-technologies-inc-to-report-third-quarter-fiscal-year-2019-results-teleconference-and-webcast-to-be-held-on-may-9-2019-300843712.html

SOURCE Palatin Technologies, Inc.

Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019

Editor Details

Last Updated: 03-May-2019